Back to User profile » Dr Chebli Mrad
Paper published by Dr Chebli Mrad:
Review
The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers
Sabari JK, Santini FC, Schram AM, Bergagnini I, Chen R, Mrad C, Lai WV, Arbour KC, Drilon A
OncoTargets and Therapy 2017, 10:1983-1992
Published Date: 6 April 2017